IGFBP5 and non-small cell lung carcinoma: Additionally, low serum IGFBP5 levels have been proven to correlate strongly with a positive nodal status, which provides diagnostic value for identifying non-small cell lung cancer progression and patient outcome (Shersher et al., 2011).